Results 191 to 200 of about 3,126,313 (204)

Prevalence of Arterial Stiffness Determined by Cardio-Ankle Vascular Index in Myeloproliferative Neoplasms. [PDF]

J Clin Med
Jindaluang T, Rattarittamrong E, Chai-Adisaksopha C, Piriyakhuntorn P, Norasetthada L, Tantiworawit A, Rattanathammethee T, Hantrakool S, Hantrakun N, Punnachet T, Niprapan P, Gunaparn S, Phrommintikul A.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Essential thrombocythemia: challenges in clinical practice and future prospects.

Blood, 2022
Essential thrombocythemia (ET) was described in 1934 and in the intervening time progress has been achieved in better understanding molecular pathogenesis and which patients may have greatest risk of progression or vascular events.
A. Godfrey, A. Green, C. Harrison
semanticscholar   +1 more source

Essential Thrombocythemia: A Review.

Journal of the American Medical Association (JAMA)
Importance Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding.
A. Tefferi, N. Gangat, G. G. Loscocco, P. Guglielmelli, N. Szuber, A. Pardanani, A. Orazi, T. Barbui, A. Vannucchi   +8 more
semanticscholar   +1 more source

Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia

Platelets, 2020
Essential thrombocythemia (ET) is characterized by persistently elevated platelet counts and an increased risk of thromboembolic events. Dysregulated expression of small noncoding microRNAs (miRNAs) have been shown in ET and may influence platelet ...
Jenny Q D Tran, O. H. Pedersen, M. Larsen, E. Grove, S. Kristensen, A. Hvas, P. Nissen   +6 more
semanticscholar   +1 more source

The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study

European Journal of Haematology, 2020
In patients with essential thrombocythemia (ET), after the JAK2V617F driver mutation, mutations in CALR are common (classified as type 1, 52‐bp deletion or type 2, 5‐bp insertion).
M. P. Pérez Encinas, M. Sobas, M. Gómez-Casares, A. Abuín Blanco, María Soledad Noya Pereira, J. Raya, M. Andrade-Campos, A. Álvarez Larrán, K. Lewandowski, Szukalski Łukasz, J. C. Hernández Boluda, F. Ferrer-Marín, M. Fox, A. Gołos, M. Gasior Kabat, E. Magro Mazo, A. Czyż, Alejandro Martín Martín, Beatriz Bellosillo Paricio, C. Quinteiro García, J. M. González Martín, R. Stuckey   +21 more
semanticscholar   +1 more source

Essential Thrombocythemia.

New England Journal of Medicine, 2019
Abnormal blood clotting (thrombosis) is common in people with essential thrombocythemia and causes many signs and symptoms of this condition. Clots that block blood flow to the brain can cause strokes or temporary stroke-like episodes known as transient ...
A. Tefferi, A. Pardanani
semanticscholar   +1 more source

Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia

Current Hematologic Malignancy Reports, 2022
I. Krečak, M. Lucijanić, S. Verstovsek
semanticscholar   +1 more source

Human medicines European public assessment report (EPAR): Xagrid, anagrelide, Thrombocythemia, Essential, Date of authorisation: 15/11/2004, Revision: 34, Status: Authorised

Case Medical Research, 2019

semanticscholar   +1 more source